FIELD: pharmaceutics.
SUBSTANCE: pharmaceutical composition for treating a disease selected from Alzheimer's disease, Parkinson's disease, inflammation, pain, diabetes and vascular dementia, contains 40–90 wt.% of alginic oligosaccharide diacid and 8–50 wt.% of an excipient, selected from starch and/or cellulose, from 0 to 10 wt.% binder and from 0.1 to 3 wt.% lubricant; binder is at least one of starch, sodium carboxymethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methylcellulose and polyvinylpyrrolidone; lubricant is at least one substance selected from talc powder, magnesium stearate, silica gel micropowder and hydrogenated vegetable oil, particle size of the alginic oligosaccharide diacid is controlled so that 100% passes through 60 mesh sieve and more than 70% passes through 100 mesh sieve. Invention also discloses the use of the pharmaceutical composition when preparing a medicinal product, a method of treating a patient, a pharmaceutical composition, a method of producing the pharmaceutical composition.
EFFECT: group of inventions provides stability and high rate of disintegration and dissolution.
22 cl, 5 dwg, 2 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITIONS COMPRISING 5,8,14-TRIAZATETRACYCLO[10,3,1,0(2,11),0(4,9)HEXADECA-2( 11),3,5,7,9-PENTAENE | 2002 |
|
RU2272629C2 |
WATER-SOLUBLE FILMS CONTAINING LOW-VISCOSITY ALGINATES | 2006 |
|
RU2445977C2 |
NEW COMPOSITION OF LAPATINIB AS A SOLID DOSAGE FORM FOR ORAL USE AND A METHOD OF ITS MANUFACTURE | 2019 |
|
RU2821950C2 |
METHOD FOR PREPARING STABLE PHARMACEUTICAL COMPOSITIONS IN OMEPRAZOLE-CONTAINING TABLET FORMULATION AND PHARMACEUTICAL COMPOSITION PREPARED BY THIS METHOD | 2003 |
|
RU2257890C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING SIGMA RECEPTOR LIGANDS | 2010 |
|
RU2549882C2 |
METHOD OF OBTAINING QUICK-DISSOLVING SODIUM ALGINATE | 2013 |
|
RU2540946C1 |
METHOD OF ABATEMENT OF HEARTBURN AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) BY MEANS OF SPECIAL POLYSACCHARIDES | 2007 |
|
RU2432167C2 |
COMPOSITIONS CONTAINING POLYSACCHARIDE MATRIX FOR CONTROLLED RELEASE OF ACTIVE INGREDIENTS | 2017 |
|
RU2748261C2 |
PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE OF ACTIVE SUBSTANCES AND METHOD FOR ITS PREPARING | 2003 |
|
RU2291711C2 |
SOLID PHARMACEUTICAL PREPARATION, METHOD OF ITS PREPARATION AND USE | 2021 |
|
RU2809722C1 |
Authors
Dates
2024-04-08—Published
2020-10-26—Filed